首页> 外文OA文献 >Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of Bi 187004, an Inhibitor of 11beta-hydroxysteroid Dehydrogenase-1, in Healthy Male Volunteers With Overweight or Obesity

【2h】

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of Bi 187004, an Inhibitor of 11beta-hydroxysteroid Dehydrogenase-1, in Healthy Male Volunteers With Overweight or Obesity

机译：单次口服剂量，乳头剂量的安全性，耐受性，药代动力学和药效学，11beta-羟类脱氢酶-1的抑制剂，具有超重或肥胖的健康男性志愿者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Susanna Bianzano; Tim Heise; Arvid Jungnik; Cornelia Schepers; Corinna Schoelch; Ulrike Gräfe-Mody;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers. [J] . Huttner S, Graefe Mody EU, Withopf B, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2008,第10期

机译：在健康男性志愿者中，单次口服剂量的BI 1356（一种二肽基肽酶4的抑制剂）的安全性，耐受性，药代动力学和药效学。
2. SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS. [J] . Koenen R., Fowler A., Gupta A., Clinical Pharmacology and Therapeutics . 2016,第Suppla1期

机译：BI 1021958（一种新的CRTH2拮抗剂）在健康男性志愿者中的单剂量口服剂量的安全性，耐受性，药代动力学和药物动力学。
3. Poster #031: Safety, Tolerability, Pharmacokinetics and Pharmaco-dynamics of Single and Multiple, Oral Doses of BI 187004, a Selective 11β-hydroxysteroid Dehydrogenase1 Inhibitor, in Healthy Subjects and Patients With Type 2 Diabetes Mellitus [J] . Jing Wu, Valerie Nock, Arvid Jungnik, Clinical pharmacology in drug development . 2016,第Suppla1期

机译：海报＃031：单一和多种口服剂量的安全性，可耐药性，药代动力学和药物动力学，BI 187004，一种选择性11β-羟类脱氢酶1抑制剂，健康受试者和2型糖尿病患者
4. Safety, tolerability, pharmacodynamics and pharmacokinetics following single subcutaneous dosesof a teverelix depot formulation in healthy male volunteers [C] . C. MacLean, F. Larsen, R. Piechatzek, Annual meeting exposition of the Controlled Release Society . 2005

机译：在健康男性志愿者中单次皮下注射Teverelix储库制剂后的安全性，耐受性，药效动力学和药代动力学
5. Safety tolerability pharmacokinetics and pharmacodynamics of single oral doses of BI 187004 an inhibitor of 11beta-hydroxysteroid dehydrogenase-1 in healthy male volunteers with overweight or obesity [O] . Susanna Bianzano, Tim Heise, Arvid Jungnik, 2021

机译：单次口服剂量乳头剂量的安全性耐受性药代动力学和药效学11beta-羟类脱氢酶-1的抑制剂具有超重或肥胖的健康男性志愿者
6. Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics: results from single oral dose studies in healthy volunteers [O] . Stoch, S Aubrey, Zajic, Stefan, Stone, Julie A, 2013

机译：Odanacatib，一种治疗骨质疏松症的选择性组织蛋白酶K抑制剂：安全性，耐受性，药代动力学和药效学：健康志愿者单次口服剂量研究的结果

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of Bi 187004, an Inhibitor of 11beta-hydroxysteroid Dehydrogenase-1, in Healthy Male Volunteers With Overweight or Obesity

著录项

引文网络

相似文献

相关主题

期刊订阅